Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1990 1
1993 1
1994 2
1995 5
1996 1
1997 1
1998 3
1999 2
2001 2
2002 2
2003 3
2004 1
2005 3
2006 2
2007 2
2008 3
2010 1
2011 1
2012 1
2013 1
2016 1
2018 2
2019 1
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year
Filters applied: . Clear all
Page 1
Validation of Thiosemicarbazone Compounds as P-Glycoprotein Inhibitors in Human Primary Brain-Blood Barrier and Glioblastoma Stem Cells.
Salaroglio IC, Abate C, Rolando B, Battaglia L, Gazzano E, Colombino E, Costamagna C, Annovazzi L, Mellai M, Berardi F, Capucchio MT, Schiffer D, Riganti C. Salaroglio IC, et al. Among authors: costamagna c. Mol Pharm. 2019 Aug 5;16(8):3361-3373. doi: 10.1021/acs.molpharmaceut.9b00018. Epub 2019 Jul 2. Mol Pharm. 2019. PMID: 31265310 Free article.
Fluoride effects: the two faces of janus.
Gazzano E, Bergandi L, Riganti C, Aldieri E, Doublier S, Costamagna C, Bosia A, Ghigo D. Gazzano E, et al. Among authors: costamagna c. Curr Med Chem. 2010;17(22):2431-41. doi: 10.2174/092986710791698503. Curr Med Chem. 2010. PMID: 20491635 Review.
Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma.
Buondonno I, Gazzano E, Jean SR, Audrito V, Kopecka J, Fanelli M, Salaroglio IC, Costamagna C, Roato I, Mungo E, Hattinger CM, Deaglio S, Kelley SO, Serra M, Riganti C. Buondonno I, et al. Among authors: costamagna c. Mol Cancer Ther. 2016 Nov;15(11):2640-2652. doi: 10.1158/1535-7163.MCT-16-0048. Epub 2016 Jul 27. Mol Cancer Ther. 2016. PMID: 27466354 Free article.
43 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page